Permeability of Metformin across an In Vitro Blood–Brain Barrier Model during Normoxia and Oxygen-Glucose Deprivation Conditions: Role of Organic Cation Transporters (Octs)
Our lab previously established that metformin, a first-line type two diabetes treatment, activates the Nrf2 pathway and improves post-stroke recovery. Metformin’s brain permeability value and potential interaction with blood–brain barrier (BBB) uptake and efflux transporters are currently unknown. M...
Main Authors: | Sejal Sharma, Yong Zhang, Khondker Ayesha Akter, Saeideh Nozohouri, Sabrina Rahman Archie, Dhavalkumar Patel, Heidi Villalba, Thomas Abbruscato |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/5/1357 |
Similar Items
-
Effect and possible mechanisms of metformin as adjuvant therapy in the management of tuberculosis: A prospective study
by: Ritu Mishra, et al.
Published: (2022-07-01) -
The Impact of Genetically Proxied AMPK Activation, the Target of Metformin, on Functional Outcome Following Ischemic Stroke
by: Mengmeng Wang, et al.
Published: (2023-05-01) -
Patients with Obesity and a History of Metformin Treatment Have Lower Influenza Mortality: A Retrospective Cohort Study
by: Tammy H. Cummings, et al.
Published: (2022-02-01) -
Editorial: New lights Through Old Windows: Metformin and Derivatives as Anti-Cancer Treatments
by: Aiman Moldasheva, et al.
Published: (2022-04-01) -
Metformin exhibits antineoplastic effects on Pten-deficient endometrial cancer by interfering with TGF-β and p38/ERK MAPK signalling
by: Anna Ruiz-Mitjana, et al.
Published: (2023-12-01)